You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an alternative browser.
You should upgrade or use an alternative browser.
brittanylancaster21
Mounjaro is a highly effective weight loss treatment, shown in clinical trials to help achieve ~20% body weight loss. It is the latest GLP1 weight loss inection, and is used for people with a body mass index (BMI) over 30.
It contains the drug tirzepatide and is a registered trademark of Eli Lilly.
It is known as Zepbound in the US, but is launching in the UK under the brand name Mounjaro.
It is injected ONCE weekly under the skin.
It contains the drug tirzepatide and is a registered trademark of Eli Lilly.
It is known as Zepbound in the US, but is launching in the UK under the brand name Mounjaro.
It is injected ONCE weekly under the skin.